A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Link
https://link.springer.com/content/pdf/10.1007/s41669-021-00298-z.pdf
Reference54 articles.
1. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589–604.
2. Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156:477-491.e1.
3. Aly A, Ronnebaum S, Patel D, Doleh Y, Benavente F. Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review. Hepatic Oncol. 2020;7:HEP27.
4. Gill J, Baiceanu A, Clark PJ, Langford A, Latiff J, Yang PM, et al. Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey. Futur Oncol. 2018;14:1701–10.
5. White LA, Menzin J, Korn JR, Friedman M, Lang K, Ray S. Medical care costs and survival associated with hepatocellular carcinoma among the elderly. Clin Gastroenterol Hepatol. 2012;10:547–54.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A meta-path, attention-based deep learning method to support hepatitis carcinoma predictions for improved cirrhosis patient management;Decision Support Systems;2024-06
2. Cost-Effectiveness of the Clinical Management of Hepatocellular Carcinoma in Four Asian-Pacific Countries;2024
3. Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?;JHEP Reports;2023-08
4. Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations;European Journal of Clinical Pharmacology;2023-05-19
5. Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?;Journal of Personalized Medicine;2022-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3